Wnt5a expression and prognosis in stage II–III colon cancer

por Lund, Cecilia Margareta, Dyhl-Polk, Anne, Nielsen, Dorte Lisbeth, Riis, Lene Buhl
Publicado 2020

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer

por James, Jaslin P., Riis, Lene Buhl, Malham, Mikkel, Høgdall, Estrid, Langholz, Ebbe, Nielsen, Boye S
Publicado 2020

Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets

por Bjerrum, Jacob Tveiten, Wang, Yulan, Zhang, Jingtao, Riis, Lene Buhl, Nielsen, Ole Haagen, Seidelin, Jakob Benedict
Publicado 2022

SMAD4 Protein Expression Is Downregulated in Ileal Epithelial Cells from Patients with Crohn's Disease with Significant Inverse Correlation to Disease Activity

por Klausen, Pia, Karstensen, John Gásdal, Coskun, Mehmet, Săftoiu, Adrian, Vilmann, Peter, Cowland, Jack Bernard, Riis, Lene Buhl
Publicado 2018

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis

por James, Jaslin Pallikkunnath, Nielsen, Boye Schnack, Christensen, Ib Jarle, Langholz, Ebbe, Malham, Mikkel, Poulsen, Tim Svenstrup, Holmstrøm, Kim, Riis, Lene Buhl, Høgdall, Estrid
Publicado 2023

COX-2–PGE(2) Signaling Impairs Intestinal Epithelial Regeneration and Associates with TNF Inhibitor Responsiveness in Ulcerative Colitis

por Li, Yuan, Soendergaard, Christoffer, Bergenheim, Fredrik Holmberg, Aronoff, David M., Milne, Ginger, Riis, Lene Buhl, Seidelin, Jakob Benedict, Jensen, Kim B., Nielsen, Ole Haagen
Publicado 2018

Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

por Seidelin, Jakob Benedict, Bahl, Martin Iain, Licht, Tine Rask, Mead, Benjamin E., Karp, Jeffrey M., Johansen, Jens Vilstrup, Riis, Lene Buhl, Galera, Marina Ramírez, Woetmann, Anders, Bjerrum, Jacob Tveiten
Publicado 2021

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types

por Kverneland, Anders Handrup, Chamberlain, Christopher Aled, Borch, Troels Holz, Nielsen, Morten, Mørk, Sofie Kirial, Kjeldsen, Julie Westerlin, Lorentzen, Cathrine Lund, Jørgensen, Lise Pyndt, Riis, Lene Buhl, Yde, Christina Westmose, Met, Özcan, Donia, Marco, Marie Svane, Inge
Publicado 2021

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

por Holmstroem, Rikke Boedker, Nielsen, Ole Haagen, Jacobsen, Søren, Riis, Lene Buhl, Theile, Susann, Bjerrum, Jacob Tveiten, Vilmann, Peter, Johansen, Julia Sidenius, Boisen, Mogens Karsbøl, Eefsen, Rikke Helene Løvendahl, Marie Svane, Inge, Nielsen, Dorte Lisbet, Chen, Inna Markovna
Publicado 2022